20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Myocardial Ischemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Garcia, V; Lucchesi, PA; Pascale, JV | 1 |
Bradford, C; Falck, JR; Gotlinger, KH; Hunter, I; Hutcheson, B; Hutcheson, R; Jiang, H; Joseph, G; Proctor, S; Rocic, P; Schwartzman, ML; Soler, A | 1 |
Abraham, NG; Gotlinger, KH; Guo, A; Hochhauser, E; Issan, Y; Kornowski, R; Laniado-Schwartzman, M; Leshem-Lev, D; Lev, E; Porat, E; Snir, E; Thompson, CI | 1 |
Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
Campbell, WB; Endsley, MP; Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Myocardial Ischemia
Article | Year |
---|---|
Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Animals, Genetically Modified; Cardiomegaly; Cardiovascular Diseases; Cytochrome P-450 Enzyme System; Heart Failure; Humans; Hydroxyeicosatetraenoic Acids; Myocardial Ischemia; Receptors, G-Protein-Coupled | 2021 |
5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Myocardial Ischemia
Article | Year |
---|---|
Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
Topics: Animals; Antibodies, Blocking; Arterioles; Capillaries; Cell Adhesion Molecules; Collateral Circulation; Coronary Vessels; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Male; Metabolic Syndrome; Myocardial Ischemia; Neutrophils; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley | 2017 |
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; AC133 Antigen; Aged; Antigens, CD; Body Mass Index; Cell Survival; Chromatography, Liquid; Diabetes Mellitus; Eicosanoids; Endothelial Cells; Female; Flow Cytometry; Glycoproteins; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipids; Male; Middle Aged; Myocardial Ischemia; Peptides; Stem Cells; Tandem Mass Spectrometry; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2004 |
Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.
Topics: Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Female; Hemodynamics; Hydroxyeicosatetraenoic Acids; Ischemic Preconditioning, Myocardial; Male; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2006 |
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Enzyme Inhibitors; Hemodynamics; Hydroxyeicosatetraenoic Acids; Mixed Function Oxygenases; Myocardial Ischemia; Myocardial Reperfusion Injury; Spectrometry, Mass, Electrospray Ionization; Sulfones | 2006 |